The literature shows that CEA, the degree of differentiation, and the extent of tumor infiltration are independent risk factors for rectal cancer (22, 23), and that CEA and the degree of differentiation are also poor prognostic factors for combined neoadjuvant treatment and TME in LARC (24–26). The gene discussed is CEACAM5; the disease is rectal cancer.